← Leaderboards
Andrew McNeal
University Of California, San Francisco
$58,242
Attributed
$58,242
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.8K · FY2019–20$50K$37.5K$25K$12.5K$0
'19
'20
Funding mix
By agency
NIH$58,242 · 1
By mechanism
F31$58,242 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- John Matthew Inadomi$9,020,701
- Matthew D Stachler$2,885,743
- Alan Ashworth$14,084,307
- Robert Laird Judson-Torres$4,354,929
- David R Raleigh$8,678,111
Others in their field
Other Emerging Leaders on “Benign”
- Nikej Shah · Nirsum Laboratories, Inc.$7,722,108
- Leonard Freedman · Leidos Biomedical Research, Inc.$6,934,050
- Gabriel Nestor Sanchez · Enspectra Health, Inc.$5,942,187
- Anil V Parwani · Ohio State University$5,256,915
- Kristina L Penniston · University Of Wisconsin-Madison$5,230,206
- Vera Hoffman · Reveal Pharma$4,535,285
Research focus
BenignBraf GeneCell CycleCell Cycle ArrestCell Cycle InhibitionCellsClustered Regularly Interspaced Short Palindromic RepeatsCutaneous MelanomaDetectionDosageDown-RegulationEarly DiagnosisElementsEpigenetic ProcessEventGenesGeneticGenetic EngineeringGenome EngineeringGrowthHuman Dna SequencingIncidenceInhibitor/AntagonistAdaptor Signaling Protein